Cargando…
Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation
OBJECTIVES: Type 1 diabetes (T1D) is caused by progressive immune-mediated loss of insulin-producing β-cells. Inflammation is detrimental to β-cell function and survival, moreover, both apoptosis and necrosis have been implicated as mechanisms of F062-cell loss in T1D. The receptor interacting serin...
Autores principales: | Takiishi, Tatiana, Xiao, Peng, Franchimont, Marie, Gilglioni, Eduardo H., Arroba, Erick N., Gurzov, Esteban N., Bertrand, Mathieu JM., Cardozo, Alessandra K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932129/ https://www.ncbi.nlm.nih.gov/pubmed/36707047 http://dx.doi.org/10.1016/j.molmet.2023.101681 |
Ejemplares similares
-
HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2
por: Wagner, Roland N., et al.
Publicado: (2015) -
Advances in RIPK1 kinase inhibitors
por: Chen, Lu, et al.
Publicado: (2022) -
The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020) -
Ripk1 and haematopoiesis: a case for LUBAC and Ripk3
por: Annibaldi, Alessandro, et al.
Publicado: (2018) -
Erratum: Advances in RIPK1 kinase inhibitors
Publicado: (2023)